Eventide Healthcare & Life Sciences A (ETAHX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.27: the stock has moved about 27% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerEventide Healthcare & Life Sciences A (ETAHX) trades at $51.73. Eventide Healthcare & Life Sciences A is a mutual fund focused on investing in equity and equity-related securities within the healthcare and life sciences sectors. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for ETAHX: ETAHX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Eventide Healthcare & Life Sciences A (ETAHX) Financial Services Profile
Eventide Healthcare & Life Sciences A is a financial services firm specializing in healthcare and life sciences sector investments, offering diversified exposure through equity and equity-related securities across various market capitalizations and geographies. It competes with other asset managers in a growing but competitive market.
What Is the Investment Thesis for ETAHX?
Eventide Healthcare & Life Sciences A presents an investment opportunity centered on the growth potential of the healthcare and life sciences sectors. With a beta of 1.27, the fund exhibits higher volatility compared to the broader market. The fund's strategy of investing across various market capitalizations and geographies allows it to capture diverse opportunities within the healthcare and life sciences industries. The absence of a dividend yield may deter income-focused investors, but the fund's focus on capital appreciation could appeal to growth-oriented investors. The fund's performance will be closely tied to the overall health of the healthcare and life sciences sectors, as well as its ability to identify and capitalize on promising investment opportunities.
Based on FMP financials and quantitative analysis
ETAHX Key Highlights
Market capitalization of $1.25 billion indicates a substantial asset base.
- Beta of 1.27 suggests higher volatility compared to the overall market.
- Investment focus on healthcare and life sciences sectors provides targeted exposure to these industries.
- Flexibility to invest in companies of any market capitalization allows for diversification across the sector.
- Absence of dividend yield may appeal to growth-oriented investors seeking capital appreciation.
Who Are ETAHX's Competitors?
ETAHX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AEMGX Acadian Emerging Markets Investor | $35.98 | +0.93% | $1.95B | — |
| AEMZX Acadian Emerging Markets Portfolio Class I | $35.98 | +0.90% | $1.89B | — |
| AOOIX American Century One Choice 2045 Portfolio - I Class | $18.79 | +0.54% | $1.24B | — |
| AROIX American Century One Choice 2045 Portfolio Investor Class | $18.75 | +0.59% | $1.23B | — |
| ARWIX American Century One Choice 2025 Portfolio Investor Class | $13.22 | -0.75% | $1.30B | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ETAHX's Key Strengths?
Specialized focus on healthcare and life sciences sectors.
- Flexibility to invest in companies of any market capitalization.
- Ability to invest in international companies through ADRs.
- Experienced investment management team.
What Are ETAHX's Weaknesses?
Concentration risk due to focus on a single sector.
- Potential for higher volatility compared to broader market indices.
- Dependence on the performance of the healthcare and life sciences sectors.
- Absence of dividend yield may deter income-focused investors.
What Are the Key Risks for ETAHX?
Economic downturns affecting healthcare spending and investment.
- Regulatory changes impacting the healthcare and life sciences sectors (e.g., drug pricing reforms).
- Geopolitical risks impacting international investments.
- Competition from other asset managers offering similar products.
- Concentration risk due to focus on a single sector.
What Are ETAHX's Competitive Advantages?
- Expertise in healthcare and life sciences sectors.
- Established track record of investment performance.
- Diversified portfolio across various market capitalizations and geographies.
What Does ETAHX Do?
Eventide Healthcare & Life Sciences A is a mutual fund that directs its investments towards the healthcare and life sciences sectors. The fund operates under the principle of allocating at least 80% of its net assets, in addition to any borrowings for investment purposes, into equity and equity-related securities. These securities encompass a range of financial instruments, including common stock, options, preferred stock, and convertible debt. The fund's investment strategy is not confined by geographical boundaries, as it is authorized to invest, without limitation, in securities of companies located outside the United States. These investments can be made either directly or through American Depositary Receipts (ADRs). Eventide Healthcare & Life Sciences A does not restrict its investments based on market capitalization, allowing it to invest in companies of any size, from small-cap to large-cap enterprises. This flexibility enables the fund to capture opportunities across the entire spectrum of the healthcare and life sciences industries, adapting to market dynamics and seeking optimal returns for its investors. The fund's approach reflects a commitment to providing investors with exposure to the growth potential of the healthcare and life sciences sectors, while also maintaining a diversified portfolio to mitigate risk.
What Products and Services Does ETAHX Offer?
- Invests primarily in equity and equity-related securities.
- Focuses on companies within the healthcare and life sciences sectors.
- Invests in companies of any market capitalization.
- May invest in securities of companies domiciled outside the United States.
- Utilizes American Depositary Receipts (ADRs) for international investments.
- Aims to provide investors with exposure to the growth potential of the healthcare and life sciences sectors.
How Does ETAHX Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Aims to achieve capital appreciation for investors through strategic investments in healthcare and life sciences companies.
- Seeks to outperform its benchmark index by actively managing its portfolio and identifying promising investment opportunities.
What Industry Does ETAHX Operate In?
Eventide Healthcare & Life Sciences A operates within the asset management industry, specifically focusing on the healthcare and life sciences sectors. The asset management industry is characterized by intense competition, with numerous firms offering a wide range of investment products and services. The healthcare and life sciences sectors are driven by factors such as aging populations, technological advancements, and increasing healthcare spending. These sectors are subject to regulatory scrutiny and are influenced by factors such as drug pricing and healthcare reform. Eventide Healthcare & Life Sciences A competes with other asset managers, such as AEMGX, AEMZX, AOOIX, AROIX, and ARWIX, in attracting investors seeking exposure to the healthcare and life sciences sectors.
Who Are ETAHX's Key Customers?
- Individual investors seeking exposure to the healthcare and life sciences sectors.
- Institutional investors, such as pension funds, endowments, and foundations.
- Financial advisors who recommend the fund to their clients.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
ETAHX Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on healthcare and life sciences sectors.
- Flexibility to invest in companies of any market capitalization.
- Ability to invest in international companies through ADRs.
- Experienced investment management team.
Bear Case
- Concentration risk due to focus on a single sector.
- Potential for higher volatility compared to broader market indices.
- Dependence on the performance of the healthcare and life sciences sectors.
- Absence of dividend yield may deter income-focused investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ETAHX Latest News
No recent news available for ETAHX.
ETAHX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ETAHX.
Price Targets
Wall Street price target analysis for ETAHX.
ETAHX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ETAHX; grades run from A+ (80-100) to F (below 30).
ETAHX Financials Stock FAQ
What regulatory challenges does Eventide Healthcare & Life Sciences A face?
Eventide Healthcare & Life Sciences A faces regulatory challenges related to its investments in the healthcare and life sciences sectors, which are subject to extensive government regulation. These regulations can impact drug pricing, healthcare reimbursement, and product approvals.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data based on available information as of 2026-03-17.
- Investment decisions should be based on individual risk tolerance and financial goals.